Moderna led S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S. The biotech company is developing a vaccine for …
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.